Publications '19 - Present

86. Xie, M., Chia, R. H., Li, D., Teo, F. X., Krueger, C., & Sabapathy, K. (2021). Functional interaction between macrophages and hepatocytes dictate the outcome of liver fibrosis. Life Science Alliance, 4(4), e202000803. https://doi.org/10.26508/lsa.202000803

85. Tan, C. T., Chang, H. C., Zhou, Q., Yu, C., Fu, N. Y., Sabapathy, K., & Yu, V. C. (2021). MOAP-1-mediated dissociation of p62/SQSTM1 bodies releases Keap1 and suppresses Nrf2 signaling. EMBO Reports, 22(1), e50854. https://doi.org/10.15252/embr.202050854

84. Gatellier, L., Matsuda, T., Sabapathy, K., Dai, M., Dewi, L., Huong, T. T., Kardinah, K., Thuan, T. V., Park, J. B., He, J., Nansalmaa, E., Luvsandorj, B., Hwang, W., Sengar, M., Pramesh, C. S., & Suzuki, T. (2020). An Asian Body to Tackle Cancers in Asia - The Asian National Cancer Centers Alliance. Asian Pacific Journal of Cancer Prevention, 21(5), 1207–1212. https://doi.org/10.31557/APJCP.2020.21.5.1207

83. Wang, C., Teo, C. R., & Sabapathy, K. (2020). p53-Related Transcription Targets of TAp73 in Cancer Cells-Bona Fide or Distorted Reality?. International Journal of Molecular Sciences, 21(4), 1346. https://doi.org/10.3390/ijms21041346

82. Kumar, R., & Sabapathy, K. (2019). RNF4-A Paradigm for SUMOylation-Mediated Ubiquitination. Proteomics, 19(21-22), e1900185. https://doi.org/10.1002/pmic.201900185

81. Ubby, I., Krueger, C., Rosato, R., Qian, W., Chang, J., & Sabapathy, K. (2019). Cancer therapeutic targeting using mutant-p53-specific siRNAs. Oncogene, 38(18), 3415–3427. https://doi.org/10.1038/s41388-018-0652-y

80. Sabapathy, K., & Lane, D. P. (2019). Understanding p53 functions through p53 antibodies. Journal of Molecular Cell Biology, 11(4), 317–329. https://doi.org/10.1093/jmcb/mjz010